Succeeder SF-8300 Fully Automated Coagulation Analyzer
The Succeeder SF-8300 is a flagship fully automated coagulation analyzer with 12-channel parallel testing for up to 600 PT tests/hour using optical, mechanical, chromogenic, and immunoturbidimetric detection. Designed for enterprise and reference labs, it measures PT, APTT, TT, FIB, D-Dimer, and 40+ parameters via quad-method integration, features dual auto-loader, reagent refrigeration, 15-inch touchscreen, built-in printer, and FHIR/HL7 LIS connectivity for ultra-high-throughput, precision clotting analysis in plasma samples.
Description
Coagulation Parameters: Elite Hemostasis Profiling The Succeeder SF-8300 offers an unparalleled hemostasis portfolio including prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB), D-Dimer (D-D), anti-thrombin III (AT-III), protein C/S, lupus anticoagulant (LA), von Willebrand factor (vWF:Ag, vWF:RCo), ADAMTS13, full intrinsic/extrinsic factor assays (II–XII), and specialized panels like thrombophilia, heparin resistance, and clot waveform analysis. This elite suite enables definitive diagnosis of rare coagulopathies, real-time TDM for DOACs, and AI-scored DIC/PE risk, empowering transfusion medicine, stroke units, and research centers with gold-standard data.
Parameters Measured: Quantifies 40+ parameters with extreme linearity (e.g., PT 5–200 s, APTT 10–300 s, FIB 0.05–20 g/L, D-D 0.01–50 µg/mL, vWF:RCo 1–200%) using quad-detection: optical turbidity for inhibitors, mechanical viscosity for weak clots, chromogenic for enzyme kinetics, and immunoturbidimetric for proteins. Real-time multi-wavelength (405/575/630/800 nm) monitoring, clot waveform analytics, and AI-driven pattern recognition deliver CV <1%, with automated flags for pre-analytical errors, biphasic curves, or hyperfibrinolysis per CLSI H59-A and ISTH guidelines.
Sample Requirements: Auto-aspirates 5–40 µL of citrated plasma from dual 400-position auto-loaders (primary tubes with barcode/QR), supporting venous, capillary, or cord blood. Features dynamic auto-dilution (1:2–1:500), ultra-low dead volume (<100 µL), and triple-wash probe with liquid level/clot detection; zero carryover (<0.05%) ensures integrity in neonatal, serial TDM, or high-throughput batch runs.
Throughput: Achieves up to 600 PT tests per hour (or 450 APTT) across 12 parallel channels, engineered for national reference labs processing 10,000–20,000 tests daily. Dual auto-loaders with continuous feed, predictive batch optimization, and <60-second STAT TAT enable true 24/7 automation, with seamless integration to track systems for chemistry/immunoassay consolidation on one sample.
Technology: Integrates quad-method detection per channel—optical (multi-angle scatter), mechanical (dual magnetic viscosity), chromogenic (kinetic absorbance), and immunoturbidimetric (latex-enhanced)—with 37°C precision incubation across 30 reagent positions. AI-powered clot waveform analysis, predictive maintenance, and self-calibration (multi-lot) ensure <0.5% drift; compliant with CLSI, IFCC, CAP, and ISO 15189 for reference-grade performance in complex matrices.
User Interface and Storage: Features a 15-inch high-resolution capacitive touchscreen with 3D waveform visualization, predictive analytics dashboards, and multilingual interface (up to 12 languages, including English, French, Arabic, and Chinese). Stores 100,000+ results with full audit trails, reaction spectra, and patient-linked QC; built-in high-speed thermal printer with auto-duplex, plus USB/LAN/RS232/Wi-Fi/5G for HL7/FHIR LIS/HIS integration, cloud backup, and encrypted exports in CSV/XML/PDF/HL7.
Reagent System: Open system with 30 refrigerated (2–10°C, 48 h) incubation positions and 5 diluent slots for liquid/lyophilized reagents, supporting Succeeder’s ultra-stable kits. Auto-RFID/NFC inventory tracking, micro-dispensing (3–20 µL/test), and 96-hour calibration stability reduce costs by 70%; three-level QC, real-time consumption forecasting, and waste minimization optimize enterprise-scale operations.
Dimensions and Portability: Enterprise workstation at 1,500 × 900 × 1,400 mm (W × D × H) weighs 220 kg, with modular expansion bays and conveyor interfaces. Low power (≤1,200 VA) and quiet operation (<65 dB) fit 15–35°C ambient with 20–85% humidity, with seismic anchoring, lockable casters, and UPS-ready power for mission-critical labs.
- Throughput: Up to 600 PT tests/hour
- Detection Channel: 12 parallel channels (optical + mechanical + chromogenic + immunoturbidimetric).
- Detection Principle: Quad-method clotting with AI waveform and spectral analysis.
- Detection Items: PT, APTT, TT, FIB, D-Dimer, AT-III, PC/PS, LA, vWF:Ag/RCo, ADAMTS13, Factors II–XII, DOAC monitoring; alarms for pre-analytical/clot anomalies.
- Built-in high-speed thermal printer, supports external printers. Multi-builtin print templates available.
- 100,000 sample results, including parameters, full spectra, waveforms, and patient information.
- Sample modes: Citrated plasma; dual auto-loader with barcode/QR and dynamic dilution.
